- Indonesia
- Malaysia
- Singapore
- Thailand
- Vietnam
Quotient and Transmedic sign distribution agreement in Southeast Asia
Quotient and Transmedic have signed a distribution agreement, which will enable Transmedic to distribute Alba by Quotient® and MosaiQ™ in five countries in Southeast Asia.This significant partnership reaffirms Quotient’s commitment to grow and expand its geographical presence. It will enable both parties to introduce new quality services to the healthcare industry in Southeast Asia and enhance patient care.With a history spanning over four decades, Transmedic is a leader in medical technology. Headquartered in Singapore, the company operates in Southeast Asia. It is active in the distribution of medical devices and specialized drugs, education, and post-sales support.The distribution agreement takes effect immediately and will cover the following five countries in Southeast Asia:
Trending Topics
Our passion for the work we do is matched only by our commitment to consistently provide the best customer experience possible.
-
Alba Bioscience completes UK NHS Evergreen Sustainable Supplier Assessment and achieves Level 2
Alba Bioscience is pleased to have completed the UK National Health Service (NHS) Evergreen Sustainable Supplier Assessment. The Assessment is a self-assessment and reporting tool and resulted in Alba Bioscience receiving a Level 2: Comprehensive net zero targets and reporting
-
Launch of AliveDx Scientific Insights Center
We are excited to announce the launch of the AliveDx Scientific Insights Center on the AliveDx website. The Scientific Insights Center provides laboratorians and the medical community access to key published scientific communications. It offers valuable insights to help navigate
-
AliveDx Suisse S.A. and Sedeer Medical Services and Trading Co. LLC Sign Distribution Agreement in Qatar
AliveDx Suisse S.A. and Sedeer Medical Services and Trading Co. LLC have signed a distribution agreement, which will enable Sedeer to distribute the MosaiQ® and LumiQ™ solutions in Qatar. The distribution agreement takes effect immediately. AliveDx is committed to expanding
-
MosaiQ AiPlex® Celiac Disease (CD) system now available in the EU market and other geographies that recognize the CE mark
We are excited to announce that our IVDR-CE marked MosaiQ AiPlex® Celiac Disease (CD) system is now available in the EU market and other geographies that recognize the CE mark (pending local registration in some countries). Celiac Disease is a
-
AliveDx Announces Multiple Evaluation Sites of its MosaiQ® Solution
AliveDx is dedicated to expanding its reach and presence across diverse regions, with the goal of delivering both clinical and economical value to clinicians by reducing the time to diagnosis for patients suffering from autoimmune and allergy diseases. We are
-
Join us at the upcoming International Friday Meeting
We are delighted to speak at the upcoming International Friday Meeting on Friday, 6 December 2024 at 6:30AM CET. The International Friday Meeting is a monthly meeting, held on the first Friday of the month, hosted by Pr. Yehuda Shoenfeld.
